ENVESTNET ASSET MANAGEMENT INC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,436
-90.3%
10,132
-14.1%
0.00%
Q4 2021$108,000
-91.7%
11,796
-78.7%
0.00%
-100.0%
Q4 2019$1,302,000
+32.9%
55,406
+4.6%
0.00%0.0%
Q3 2019$980,000
+8.2%
52,979
+8.7%
0.00%0.0%
Q2 2019$906,000
-27.2%
48,732
-4.3%
0.00%
-50.0%
Q1 2019$1,245,000
+7.0%
50,932
+13.5%
0.00%0.0%
Q4 2018$1,164,000
+2138.5%
44,885
+3257.1%
0.00%
Q2 2018$52,000
+40.5%
1,337
-0.1%
0.00%
Q1 2018$37,0001,3390.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders